Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hypoxic Tumours”

269 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 269 results

Early research (Phase 1)Study completedNCT01149915
What this trial is testing

Study of Hypoxia-Activated Prodrug TH-302 to Treat Advanced Leukemias

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphoblastic LeukemiaChronic Myelogenous Leukemia+3 more
Threshold Pharmaceuticals 40
Large-scale testing (Phase 3)Active Not RecruitingNCT04736706
What this trial is testing

Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib, Versus Pembrolizumab and Lenvatinib, for Treatment of Advanced Clear Cell Renal Cell Carcinoma (MK-6482-012)

Who this might be right for
Carcinoma, Renal Cell
Merck Sharp & Dohme LLC 1,854
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07822347
What this trial is testing

Research on NI-FAPI-04 for the Treatment of Hypoxic and Fibroblast Activation Protein Related Tumors

Who this might be right for
Tumor
Peking Union Medical College Hospital 20
Not applicableStudy completedNCT04320108
What this trial is testing

ESWT for Shoulder Pain in Patients With Brain Damage

Who this might be right for
Brain Damage, HypoxicStrokeBrain Tumor+1 more
Bundang CHA Hospital 6
Not applicableUnknownNCT04727034
What this trial is testing

Efficacy and Safety of Remimazolam Tosylate for Sedation in Gastroscopy

Who this might be right for
HypoxiaGastric CancerSedation Complication+1 more
RenJi Hospital 1,800
Not applicableUnknownNCT06007989
What this trial is testing

Assessing the Relationship Between Hypoxia and the Immune Environment in Myeloma Patients (CHIME)

Who this might be right for
Myeloma
The Christie NHS Foundation Trust 10
Testing effectiveness (Phase 2)Study completedNCT02471313
What this trial is testing

Integrated Imaging Strategy to Phenotype Progression of Liver Tumors During and After Chemoembolization

Who this might be right for
Liver CancerLiver NeoplasmHepatocellular Carcinoma+1 more
National Institutes of Health Clinical Center (CC) 3
Not applicableEnded earlyNCT01617980
What this trial is testing

Multimodal Hypoxia Imaging and Intensity Modulated Radiotherapy for Inoperable Non-small-cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
German Cancer Research Center 4
Not applicableStudy completedNCT01816607
What this trial is testing

Functional MRI of Hypoxia-mediated Rectal Cancer Aggressiveness

Who this might be right for
Rectal DiseasesRectal NeoplasmsGastrointestinal Diseases+1 more
University Hospital, Akershus 192
Very early researchLooking for participantsNCT05632562
What this trial is testing

Multiparametic Metabolic and Hypoxic PET/MRI for Disease Assessment in High Grade Glioma

Who this might be right for
High Grade Glioma
University of Alabama at Birmingham 20
Early research (Phase 1)Ended earlyNCT00826930
What this trial is testing

Trans Sodium Crocetinate (TSC) Study of Intra-tumoral Oxygen Concentration, Safety, and Pharmacokinetics in Patients With High Grade Glioma

Who this might be right for
High Grade Glioma
Diffusion Pharmaceuticals Inc 1
Early research (Phase 1)Looking for participantsNCT04846309
What this trial is testing

Hypoxia Imaging for Esophageal Cancer to Guide Personalized Radiation Therapy

Who this might be right for
Esophageal Cancer
University of Utah 16
Not applicableLooking for participantsNCT06475261
What this trial is testing

Tissue Oximetry's Measurement in Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy

Who this might be right for
Oxygen DeficiencyAcute Kidney InjuryOvarian Carcinoma
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 50
Not applicableUnknownNCT04500392
What this trial is testing

High-flow Nasal Cannula Oxygenation Decrease Hypoxia in Sedated Gastrointestinal Endoscopes in Obesity

Who this might be right for
HypoxiaGastric CancerEsophagus Cancer+2 more
RenJi Hospital 1,000
Large-scale testing (Phase 3)Not Yet RecruitingNCT06477939
What this trial is testing

Study of Adding or Not Liposomal Transcrocetin (L-TC) With Concomitant HypoFractionated Radiation ThErapy and TEmozolomide in Newly Diagnosed GLioblastoma (GBM) Patients

Who this might be right for
Glioblastoma
Institut de cancérologie Strasbourg Europe 554
Testing effectiveness (Phase 2)Study completedNCT01213030
What this trial is testing

Clinical Evaluation of the New Hypoxia Imaging Agent HX4

Who this might be right for
Head and Neck CancerLung CancerLiver Cancer
Siemens Molecular Imaging 12
Not applicableActive Not RecruitingNCT01181375
What this trial is testing

Predictive Assays In Cervix Cancer

Who this might be right for
Cervical Cancer
University Health Network, Toronto 500
Very early researchStudy completedNCT05250895
What this trial is testing

BOLD MRI and FMISO PET for the Assessment of Hypoxic Tumor Microenvironment in Patients with Oligometastatic Liver Cancer Undergoing Yttirum-90 Selective Internal Radiation Therapy

Who this might be right for
BCLC Stage a Hepatocellular CarcinomaBCLC Stage B Hepatocellular CarcinomaBCLC Stage C Hepatocellular Carcinoma+1 more
Emory University 9
Not applicableEnded earlyNCT03365076
What this trial is testing

Exercise for Improving Prostate Oxygenation in Prostate Tumors (Exipox)

Who this might be right for
Prostate CancerPhysical ActivityHypoxia
University Hospital of North Norway 1
Testing effectiveness (Phase 2)Looking for participantsNCT07049926
What this trial is testing

Substudy 03C: A Study of Combination Therapies in Participants With Renal Cell Carcinoma With Recurrent Disease During or After Anti-PD-(L)1 Therapy (MK-3475-03C/KEYMAKER-U03)

Who this might be right for
Renal Cell Carcinoma
Merck Sharp & Dohme LLC 140
Next Page